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V I R O L O G Y
Human adenovirus type 26 uses sialic acid–bearing 
glycans as a primary cell entry receptor
Alexander T. Baker1, Rosie M. Mundy1, James A. Davies1, Pierre J. Rizkallah2, Alan L. Parker1*
Adenoviruses are clinically important agents. They cause respiratory distress, gastroenteritis, and epidemic kerato­
conjunctivitis. As non­enveloped, double­stranded DNA viruses, they are easily manipulated, making them pop­
ular vectors for therapeutic applications, including vaccines. Species D adenovirus type 26 (HAdV­D26) is both a 
cause of EKC and other diseases and a promising vaccine vector. HAdV­D26–derived vaccines are under investigation 
as protective platforms against HIV, Zika, and respiratory syncytial virus infections and are in phase 3 clinical trials 
for Ebola. We recently demonstrated that HAdV­D26 does not use CD46 or Desmoglein­2 as entry receptors, while 
the putative interaction with coxsackie and adenovirus receptor is low affinity and unlikely to represent the 
primary cell receptor. Here, we establish sialic acid as a primary entry receptor used by HAdV­D26. We demon­
strate that removal of cell surface sialic acid inhibits HAdV­D26 infection, and provide a high­resolution crystal 
structure of HAdV­D26 fiber­knob in complex with sialic acid.
INTRODUCTION
Adenoviruses are clinically important, both as human pathogens 
and as platforms for therapeutic applications. As pathogens, human 
adenoviruses (HAdVs) have been isolated from severe infections in 
both immunocompromised and healthy individuals (1). Some adeno-
viruses have been associated with acute infection of the eye (2), 
respiratory (3), and gastrointestinal tract (1). In rare cases, infections 
prove fatal, as observed in a recent neonatal infection of species 
D adenovirus type 56 (HAdV-D56) (4), among adult patients in 
New Jersey with HAdV-B7d (5) and infamously with HAdV-E4, 
where large epidemics of adenovirus infection have been seen in 
military recruits (6). However, most fatal infections are observed in 
immunocompromised individuals (7), such as those suffering from 
graft-versus-host disease (8) or HIV (9, 10).
Adenoviruses are classified into seven species (A to G) and be-
tween 57 and 90 types depending on the taxonomic definitions used 
(11, 12). Some adenoviruses have been studied in detail, having 
well-defined receptor tropisms, including as coxsackie and adeno-
virus receptor (CAR) (13), cluster of differentiation 46 (CD46, also 
known as membrane cofactor protein) (14), desmoglein 2 (DSG2) (15), 
or sialic acid–bearing glycans (16). However, most types have low 
seroprevalence in the population (17), though this varies significantly 
by geographical location (18, 19). Their rarity means that many types 
remain understudied, with poorly defined primary receptor interactions. 
This is especially true of the species D adenoviruses (HAdV-D), the 
largest of the adenoviral species, containing 35 of 57 canonical types (12).
Species D adenoviruses are associated with several pathogenicities. 
HAdV-D56 is a potentially fatal emergent respiratory pathogen 
composed of a recombination between four species D adenoviruses 
(4). Opportunistic adenovirus infection isolated from patients with 
HIV/AIDS are most commonly from species D, where they are as-
sociated with prolonged shedding in the gastrointestinal tract (9). 
HAdV-D has also been associated with genital disease (20). The 
species D adenoviruses are best known, however, for causing epidemic 
keratoconjunctivitis (EKC) infections, which is endemic, but not 
isolated, to Japan (21). Classically, the primary EKC causing adeno-
viruses have been HAdV-D8, HAdV-D37, and HAdV-D64 (22) 
[previously classified as 19a (23)]. More recently, other species 
D adenoviruses have been associated with EKC, including HAdV-D53 
(previously classified as HAdV-D22/H8) (24, 25), HAdV-D54 (26), 
and HAdV-D56 (27).
The double-stranded adenovirus DNA genome makes them readily 
amenable to genetic modification (28) and therefore has made them 
attractive candidates for genetic manipulation for therapeutic ap-
plications in cancer (oncolytic viruses) (29) and as vaccine vectors 
(30). Species D adenoviruses are of special interest as vaccine vectors. 
Their ability to induce robust cellular and humoral immunogenic 
responses in humans, coupled with low seroprevalence rates in the 
general population (17), makes them attractive platforms for vac-
cines, as evidenced by their progression through clinical trials for 
HIV (31), Zika (32), and Ebola treatment (33). However, there re-
mains a lack of understanding regarding their basic biology and 
mechanisms of cellular infection. This is exemplified by HAdV-D26, 
which is being investigated as a vaccine vector for Zika (32), HIV 
(34), and respiratory syncytial virus (35), and has entered phase 3 
clinical trials as an Ebola vaccine (33).
Despite its clinical success, recent findings further highlight the 
lack of clarity over the primary receptor usage of HAdV-D26. It is now 
clear that, despite previous publications to the contrary, HAdV-D26 
cannot engage CD46 as a primary cellular entry receptor (36). Instead, 
the HAdV-D26 fiber knob protein (HAdV-D26K) may engage CAR 
as a primary receptor, although the affinity of this interaction is at-
tenuated compared to the classical HAdV-C5 interaction with CAR 
due to the presence of an extended HAdV-D26 fiber knob DG loop, 
which sterically inhibits the interaction with CAR (36). The de-
duced low affinity of the interaction between CAR and HAdV-D26 
fiber knob makes it unlikely that CAR represents the definitive primary 
receptor of HAdV-D26.
Here, we demonstrate that HAdV-D26 uses sialic acid–bearing 
glycans as a primary entry receptor and that this interaction can 
form a productive infection. We solve the structure of HAdV-D26K 
in complex with sialic acid [N-acetylneuraminic acid (Neu5Ac)], 
revealing a similar topology to the known sialic acid–interacting 
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HAdV-D37 fiber knob in the sialic acid–binding pocket, but high-
light crucial mechanistic differences likely to enhance HAdV-D26 
affinity for sialic acid compared to other types.
RESULTS
HAdV-D26K has an electrostatic profile permissive to sialic 
acid interaction
Our recent findings highlight that HAdV-D26K is unlikely to use 
CD46 as a primary cellular receptor. We further confirmed this ob-
servation using surface plasmon resonance to confirm that the 
HAdV-D26 fiber knob protein does not stably interact with either 
CD46 or DSG2. A weak affinity for CAR was observed for HAdV-
D26K; however, this is unlikely to represent a primary receptor. 
Previous amino acid sequence alignments demonstrated little 
conservation of sialic acid–binding residues with the fiber knob 
domains of the known sialic acid using HAdV-G52SFK (short 
fiber knob) or canine adenovirus type-2 (CAV-2) (36). However, 
these alignments indicated that HAdV-D37, known to bind sialic 
acid in the apex of the fiber knob, bore some similarity at a se-
quence level. We sought to evaluate the ability of HAdV-D26K to 
interact with the remaining previously described adenovirus receptor, 
sialic acid.
HAdV-D37 fiber knob is identical to that of HAdV-D64 and 
highly homologous to that of HAdV-D8 (Fig. 1A). These three 
viruses have been shown to cause EKC and to interact with sialic 
acid. The closely related HAdV-D19p, differing from HAdV-D64 at 
only two residues, has also been shown to bind sialic acid, but does 
not cause EKC. We compared HAdV-D26K to these viruses to de-
termine whether a similar binding mechanism was possible.
These sialic acid–binding viruses all have highly negative predicted 
isoelectric points (pIs) (Fig. 1A). We calculated the surface electro-
static potentials of these fiber knob proteins at pH 7.35 to simulate 
the pH of extracellular fluid, using previously published crystal 
structures where available. There is no published structure of HAdV- 
D8K; thus, we generated a homology model based on the closest 
known relative with a crystal structure (Fig. 1B).
The analyzed fiber knob proteins are highly charged. We observed 
a concentration of positive charge in the central depression around 
the threefold axis, which corresponds to the previously reported sialic 
acid–binding sites (Fig. 1, B to D). HAdV-D8 has the most basic 
surface potential (Fig. 1B), followed by HAdV-D37/64 (Fig. 1C). 
HAdV-D19p is less basic due to the two amino acid substitutions, 
compared to HAdV-D37/64, though the central depression is un-
affected, as has previously been noted (Fig. 1D) (37).
HAdV-D26K has a lower predicted pI, 6.49, and a less positive 
surface potential (Fig. 1, A and E). However, the central depression 
of HAdV-D26K remains basic around the region where sialic acid is 
observed to bind in HAdV-D19p and HAdV-D37. HAdV-D26 retains 
the charge needed for sialic acid binding in the apex of the protein 
in the context of an otherwise acidic protein (Fig. 1E).
HAdV-D26 requires cell surface sialic acid for efficient 
infection
Sequence alignment of HAdV-D26K with these known sialic acid–
using viruses, bearing a positively charged apex, showed conservation 
Fig. 1. HAdV-D26K forms a local basic area in the apical depression to facilitate sialic acid binding despite an overall acidic predicted isoelectric point. (A) HAdV-D26K 
has low (56.76%) sequence identity with fiber knobs known to bind sialic acid by a similar mechanism and an acidic isoelectric point. The electrostatic potential surfaces 
of HAdV-D8K (B), HAdV-D64/37 (C), and HAdV-D19p (D) fiber knobs are highly basic, especially about the central depression about the threefold axis. (E) HAdV-D26 
fiber knob is less basic overall but maintains positive potential in the central depression. Surfaces are displayed at ±10 mV, and the two residues that differ between HAdV-D19p 
and HAdV-D37/64 are shown as green sticks.
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of key binding residues between types (Fig. 2A). We observe complete 
conservation of Tyr314 and Lys349 across the four types and conserva-
tion of Asp312 with HAdV-D8 (Fig. 2A). Furthermore, while HAdV-
D26K Tyr320 is not conserved, inspection of the crystal structure of 
HAdV-D37K and HAdV-D19p in complex with sialic acid [Protein 
Data Bank (PDB) 1UXA and 1UXB, respectively] (37) reveals this 
to be a main-chain oxygen contact, positioned similarly in HAdV-D26, 
and can be considered homologous.
To investigate the ability of HAdV-D26 to use sialic acid as a cell 
entry receptor, we used a replication-incompetent HAdV-C5 vector 
pseudotyped with the HAdV-D26 fiber knob, expressing a green 
fluorescent protein (GFP) transgene. We performed infectivity studies 
in three cell lines, with and without pretreatment with neuraminidase, 
to remove cell surface sialic acid. The tested cell lines could be infected 
by the CD46-mediated (Fig. 2B) or CAR-mediated (Fig. 2C) pathways 
to some extent, by HAdV-C5/B35K or HAdV-C5, respectively. How-
ever, infection via these routes was uninhibited by neuraminidase 
treatment. Transduction efficiency of HAdV-C5 and HAV-C5/B35K 
was actually enhanced by neuraminidase treatment in some cases, 
an effect that has been previously observed (38, 39). This has been 
suggested to be due to a reduction in the electrostatic repulsion of 
the negatively charged capsid of HAdV-C5.
Infection by the HAdV-C5/D26K pseudotype was significantly 
reduced in all three cell lines following treatment with neuraminidase 
(Fig. 2D). This inhibition is significant (P < 0.005), resulting in >5-fold 
decrease in infection in all three cell lines tested, similar to the de-
crease observed when performing similar experiments with EKC- 
causing viruses HAdV-D37/53/64, of five- to eightfold inhibition (40). 
These data indicate that HAdV-C5/D26K is using sialic acid, not 
CD46 or CAR, to infect these cells.
HAdV-D26 forms a stable complex with sialic acid
We crystallized HAdV-D26K in complex with sialic acid to clarify 
the mechanism of interaction. Refinement of structures generated 
from HAdV-D26K crystals soaked in sialic acid shows electron 
density for a small-molecule ligand in the apical depression (Fig. 3A); 
this is best described by a racemic mixture of  and  anomers, in 
conjunction with double conformations of sialic acid (Fig. 3B). The 
cubic space group (table S1) enabled assembly of the biological trimer. 
We observed three copies of sialic acid bound within the apex of the 
fiber knob trimer (Fig. 3C), as previously observed in HAdV-D37 
and HAdV-D19p.
Sialic acid binding was observed in structures crystallized at both 
pH 8.0 (PDB 6QU6) and pH 4.0 (PDB 6QU8). Observation of sialic 
acid density at high  values suggests a highly stable interaction (fig. S1). 
Electron density demonstrates the C2 carboxyl and OH groups in 
two conformations, and the C6 glycerol group is flexible, with the 
C7-C8 bond rotating to alter the orientation of the glycerol arm, 
Fig. 2. HAdV-D26K shares key binding residues with sialic acid–using adenoviruses and exploits sialic acid to infect cells. (A) Sequence alignment of HAdV-D26K 
shows conservation of key binding residues with known sialic acid–binding adenoviruses; top numbering is according to HAdV-D26K. Residues boxed in red form polar 
contacts with sialic acid, those boxed in black denote contact sialic acid via water bridge, and those boxed in orange indicate hydrophobic contacts; all HAdV-D26K polar 
contacts also form water bridges. Neuraminidase treatment does not reduce the ability of HAdV-D5/B35K (B) or HAdV-C5 (C) to infect SKOV-3 (ovarian adenocarcinoma), 
BT-20 (breast carcinoma), or MDA-231 (metastatic breast adenocarcinoma) cells, while HAdV-D5/D26K (D) is significantly inhibited. n = 3 biological replicates; error bars 
indicate ±SD.
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relative to the pyranose ring and binding pocket (Fig. 3, A and B, 
and fig. S1). The glycerol group exhibits further flexibility at the 
C8-C9 bond, making the terminal oxygen mobile. The distribution 
of the density for the glycerol group is different at each pH (fig. 
S1), suggesting that pH could affect the preferred mode of inter-
action.
The most biologically relevant sialic acid conformation places the 
carboxyl group axial to the chair conformation pyranose ring (fig. S2), 
leaving the OH group pointing away from the fiber knob and free 
to form an (2)-glycosidic bond as part of a glycan. This is suggestive 
of a terminal sialic acid residue, as the chain can extend out of the 
central depression, as was observed in the previously described 
HAdV-D37K:GD1a glycan structure (37, 41).
HAdV-D26 has a sophisticated sialic acid–binding pocket
Comparison between the HAdV-D26K and HAdV-D37K, the best 
described of the sialic acid–binding adenoviruses, reveals that several 
sialic acid contacts are conserved (Fig. 4, A and B). Lys349 and Tyr314 
are identical, and while Lys349 exhibits some flexibility, all observed 
lysine conformations form a contact with the carboxyl group of the 
sialic acid (fig. S3). While Thr319 is not conserved in HAdV-D37 
(which has a proline at this position), the main-chain oxygen contact 
to the N-acetyl nitrogen is spatially similar; hence, the bond can be 
considered homologous.
The HAdV-D26K sialic acid interface forms further contacts with 
sialic acid that are not observed in HAdV-D37K (Fig. 4, A and B). 
HAdV-D26K contacts the N-acetyl oxygen of sialic acid using Asn312, 
which forms a polar contact and a water bridge (Fig. 4A). The com-
parable residue in HAdV-D37K, Thr310, is too short to form a direct 
polar interaction (Fig. 4B); instead, a pair of water bridges is used.
In HAdV-D37, the glycerol arm of sialic acid was only contacted 
by a water bridge between Ser344 and the C7-OH. However, in 
HAdV-D26, all three OH groups in the glycerol arm form contacts. 
C7-OH is coordinated by water bridges to both Asn312 and Gln348. 
C8-OH forms a water bridge with Thr319, and C9-OH forms both a 
water bridge and a polar contact directly to Gln348. Similar to Thr310, 
the serine belonging to HAdV-D37 at position 344 is too short to 
form a polar bond equivalent to the one with Gln348.
Notably, the density for the glycerol arm of sialic acid suggests 
several possible conformations (fig. S2), which can be interpreted as 
flexibility. However, we suggest that, in HAdV-D26, this is unlikely 
since it is so well coordinated in all conformations observed, at both 
pH 8.0 and pH 4.0 (fig. S3). We propose that HAdV-D26K can form 
a stable interaction with the glycerol arm, regardless of the specific 
Fig. 3. Sialic acid binds in the apical depression of HAdV-D26 fiber knob protein. The map shows clear density for a ligand (A), which is best described by a double 
conformer of sialic acid (B). (C) Sialic acid (orange) is seen to bind in three locations in the apical depression of the HAdV-D26 fiber knob, bridging between monomers 
(shades of blue) of the trimeric assembly. Crystallization statistics are provided in table S1; 2FoFc map (blue mesh,  = 1.5) and FoFc (green mesh,  = 3.0).
Fig. 4. HAdV-D26K forms a complex interaction network of hydrophobic and 
electrostatic interactions with sialic acid. Sialic acid (orange) is seen to bind 
HAdV-D26 (A) and HAdV-D37 (B) through a network of polar contacts (red dashes) 
and hydrogen bonds (blue dashes). The interaction is stabilized by hydrophobic 
interactions (red regions on white surface) with the N-acetyl CH3 group, but different 
residues in HAdV-D26 (C) and HAdV-D37 (D). Waters are shown as cyan spheres, 
residues forming comparable contacts in HAdV-D26 and HAdV-D37 are shown as 
blue sticks, and other residues are shown as green sticks. Oxygen and nitrogen are 
seen in red and blue, respectively.
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confirmation. The variable density can be explained as the average 
distribution (or partition) of the different discrete positions.
We also observe a hydrophobic interaction in HAdV-D26 with 
the N-acetyl methyl group at C11 (Fig. 4C). A similar hydrophobic 
interaction is seen in HAdV-D37, where Tyr312 and Val322 form a 
hydrophobic patch (Fig. 4D), but the HAdV-D26 interaction appears 
to be more selective, where Ile310 and Ile324 form a hydrophobic cradle 
around the methyl group (Fig. 4C).
HAdV-D26 binds sialic acid through  
an induced-fit mechanism
We observe split density for Gln348 in both pH 8.0 (Fig. 5A) and pH 
4.0 (Fig. 5B). While conformation A can form polar contacts with 
sialic acid, conformation B points into the solvent and cannot. It is 
possible that Gln348 is flexible, but then is attracted to the charged 
density of the glycerol arm upon sialic acid interaction. We also ob-
serve greater occupancy of conformation A in the pH 8.0 structure 
(approximately 0.7), while at pH 4.0, the occupancy is evenly split. 
This suggests that the interaction may be more stable at higher pH, 
such as that associated with the pH found at the cell surface.
Ile324, which is seen to be involved in hydrophobic interactions 
with the N-acetyl methyl group (Fig. 4C), can also have multiple 
conformations. In an unliganded structure of HAdV-D26 fiber knob 
(PDB 6FJO), the long arm of Ile324 is seen to rotate (Fig. 5C). How-
ever, in the ligated structure, Ile324 occupies a single conformation 
(Fig. 5D), forming a cradle. This creates a larger hydrophobic patch 
and restricts the methyl group in space by pinching it between the 
pair of hydrophobic isoleucines, anchoring the N-acetyl group.
DISCUSSION
Other adenoviruses have been shown to interact with sialic acid. 
These include CAV-2 (42), Turkey adenovirus 3 (43), and HAdV-G52 
short fiber knob (44, 45), but these viruses interact with sialic acid 
in lateral regions of the fiber knob, dissimilar from HAdV-D26K. 
Four other HAdV fiber knob proteins (HAdV-D8/19p/37/64K) have 
been previously shown to use sialic acid, binding in the apical region. 
These viruses have high sequence similarity to each other, but not to 
HAdV-D26K, though they all share key sialic acid contact residues 
(Figs. 1A and 2A).
The structure of HAdV-D8 has not been determined, either alone 
or in complex with sialic acid, but infection by HAdV-D8 is sensitive 
to neuraminidase treatment, suggesting sialic acid utilization (46). 
Furthermore, HAdV-D8K has very high sequence homology and 
shared sialic acid contact residues with HAdV-D19p/37K, making 
it logical to expect a similar interaction mechanism. In support of this, 
Fig. 5. HAdV-D26K uses an induced-fit mechanism in sialic acid binding. HAdV-D26K residue Gln348 can occupy multiple conformations, with a greater preference for 
conformation A (capable of forming a polar contact with the glycerol arm of sialic acid) at pH 8.0 (A) than at pH 4.0 (B). (C) Ile324 has two conformations when HAdV-D26K 
is unliganded (PDB 6FJO). (D) However, upon sialic acid binding, the Ile324 adopts a single confirmation, creating a hydrophobic indentation around the N-acetyl methyl 
group bounded by Ile324, Ile310, and the ring of Tyr312.
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we observe a similar electrostatic profile in the modeled fiber knob 
as seen in HAdV-D37/64 (Fig. 1, B and C). HAdV-D64 has an identical 
fiber knob domain to that of HAdV-D37; thus, fiber knob inter-
actions with sialic acid are likely to be conserved between these types. 
HAdV-D26K conserves the key region of positive potential in the 
apical depression, but in the context of an otherwise more acidic 
protein (Fig. 1E).
Inspection of the sialic acid–binding pocket of HAdV-D26K reveals 
a much more complex mechanism of interaction than that previously 
reported for HAdV-D37K (Fig. 4) (37). The overall topology of the 
pocket is similar, with hydrophobic residues around the N-acetyl 
group and polar contacts between the carboxyl and C4-OH group. 
However, HAdV-D26K has several differences that increase the number 
of contacts between the sialic acid and the fiber knob.
Subtle sequence changes enable more numerous interactions be-
tween HAdV-D26K and sialic acid than are possible in HAdV-D37K. 
In HAdV-D37, Pro317 forms a main-chain oxygen contact to the 
nitrogen of sialic acid; however, it also creates tension, which rotates 
the N-terminal residue away from the carboxyl group of sialic acid. 
In HAdV-D26K, Tyr320, which is C-terminal of the Thr319 that is 
equivalent to Pro317 in HAdV-D37K, does not create this tension 
and enables the main-chain oxygen at position 320 to contact the 
sialic acid carboxyl group. Thr319 also forms a water bridge with the 
C8-OH group, helping to stabilize the glycerol side chain (Fig. 4A).
This is one of several examples of HAdV-D26K forming additional 
contacts with sialic acid that are not observed with HAdV-D37/19p. 
The substitution of the Thr310 and Ser344 found in HAdV-D37K for 
longer charged residues (Asn312 and Gln348, respectively) in HAdV-
D26K enables direct polar contacts, as well as additional water-bridge 
contacts. Substitution of Tyr308 and Val322 for more hydrophobic 
isoleucine residues in HAdV-D26 (Ile 310 and Ile324, respectively) 
creates a hydrophobic indentation better tailored to fit around the 
N-acetyl methyl group.
The high resolution of the datasets generated to determine the 
sialic acid–bound HAdV-D26K structure enables visualization of 
multiple residue conformations with partial occupancy. In unliganded 
structures of HAdV-D26K (PDB 6FJO), Ile324 exhibits a double 
conformer, occupying the available space (Fig. 5C). However, when 
sialic acid is bound, it is restricted to have a single conformation 
with the long arm facing away from the sialic acid site, toward the 
intermonomer cleft. Ile310 has the opposite orientation and creates 
an indentation, which cradles the methyl group of sialic acid. Tyr312 
may further contribute to the hydrophobic cradle. Tyr312 would not 
normally be considered a hydrophobic residue, but the side-chain 
oxygen faces toward the solvent, where it forms a polar interaction 
with the C4-OH on sialic acid (Fig. 4A), leaving the face of the tyrosine 
ring exposed to the methyl group, which may contribute hydrophobic 
character to the cradle. This tyrosine behaves in both a polar and 
hydrophobic manner at the same time. We suggest that the long 
arm of Ile324 adopts the sialic acid–binding conformation in re-
sponse to the hydrophobic pressure exerted by sialic acid entering 
the pocket, minimizing the exposed hydrophobic surface when un-
bound, holding the methyl group between the short arm of Ile310 
and the Tyr312 ring, making this an example of induced fit.
The double occupancy of Gln348 may indicate a second induced-fit 
mechanism. We observe two possible conformations of Gln348 (Fig. 5C). 
While conformation A does not form any contacts, conformation B 
forms a polar bond and water bridge, with the sialic acid glycerol 
group. In HAdV-D37K, the glycerol group forms only a water bridge 
from C7-OH to Ser344, the spatial equivalent of Gln348. While we 
have not determined the preferred conformation of the sialic acid 
glycerol group versus Gln348 conformation, we observed that it can 
form polar contacts with it regardless, while Gln348 is in conforma-
tion B (Fig. 5C).
We suggest that Gln348 may be labile until the binding of sialic acid. 
Upon sialic acid binding, Gln348 becomes attracted to the charged 
glycerol group, causing it to stabilize in conformation A. This has 
the effect of “locking” the glycerol side chain in place, which is further 
restrained by water-bridge contacts to Thr319 and Asn312.
Gln348 has greater occupancy in a sialic acid–binding conforma-
tion (conformation A) at pH 8.0, which corresponds more closely to 
the physiological conditions in which it would encounter at the cell 
surface (Fig. 5A). At pH 4.0, Gln348 has approximately half occu-
pancy in each conformation (Fig. 5B). This implies the possibility of 
HAdV-D26K having lower sialic acid affinity under more acidic 
conditions, such as those encountered during endosomal trafficking 
down the lysosomal pathway.
Therefore, the HAdV-D26K binding pocket to sialic acid is sum-
marized by three synchronous mechanisms: an N-acetyl anchor 
composed of a polar contact to Asn312 stabilized by a water bridge 
and an induced hydrophobic cradle around the methyl group; an 
inducible lock, where Gln348 forms a polar contact to the most terminal 
atoms in the glycerol arm, supported by a network of water bridges; 
and, last, a network of polar contacts to the carboxyl, C4 oxygen, 
and nitrogen atoms, which stabilize the pyranose ring.
This interaction in HAdV-D26K is a much more sophisticated 
binding mechanism compared to HAdV-D19p and HAdV-D37/64. 
However, the overall pocket topology and several key residues bear 
similarities. It may be unexpected to observe such similarity given 
the low level of sequence homology HAdV-D26K has to the HAdV-
D37K (56.76%, Fig. 1A). Other regions, especially the loops, have 
highly dissimilar sequences. There is precedent for this within adeno-
virus, with recombination events being reported in numerous set-
tings (23, 24).
It has previously been suggested that many of the species D adeno-
viruses may have dual sialic acid–binding affinity and CAR affinity 
(37). This has been observed in HAdV-D37/64, CAV-2 (13, 42), and, 
now, HAdV-D26 (36). The species G adenovirus HAdV-G52 has 
also been observed to bind both CAR and sialic acid, but using two 
different fiber knob proteins on the same virus and a different 
mechanism of sialic acid interaction in the knob (44), which is 
shown to bind polysialic acid (47). Previous work has proposed that 
CAR may be a receptor for many, if not all, of the species D adeno-
viruses with variable affinity (36, 37) and suggests that sialic acid 
could also be widely used (37). These findings support that assertion, 
adding another species D adenovirus, with low sequence similarity, to 
the pool of adenoviruses observed to bind both CAR and sialic acid.
HAdV-D43, HAdV-D27, and HAdV-D28 fiber knobs share high 
sequence homology with HAdV-D26K, sharing most of the critical 
binding residues, and/or having structural homologs at those positions 
(fig. S4). HAdV-D26K is the only species D adenovirus to have a 
glutamine at position 348 (HAdV-D26K numbering), though many 
have the shorter (but similarly charged) asparagine at this location, 
share the serine or similarly charged residue found in HAdV-D37K, 
or have an asparagine that could behave similarly to glutamine. 
However, HAdV-D8 has an uncharged alanine at this position, sug-
gesting that a charged residue may not be strictly required for sialic 
acid binding, though it may alter affinity (fig. S4).
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HAdV-D8K shares an asparagine at the same position as HAdV-
D26K, which we have shown to form polar and water-bridge 
contacts to sialic acid (Fig. 4A). While this is unique among the 
classical EKC-causing viruses HAdV-D19p/37/64, it is the most 
common residue at this position in the species D adenoviruses 
(fig. S4).
The HAdV-D26K surface electrostatics most closely resemble 
those of HAdV-D19pK. HAdV-D19pK is capable of binding sialic acid 
(37), and a limited effect is seen on infection of A549 cell binding after 
neuraminidase treatment to remove cell surface sialic acid (46). 
HAdV-D19p binding to Chang C (human conjunctival) cells was 
completely unaffected by neuraminidase treatment, though binding 
was very low regardless of neuraminidase treatment (38). This in-
ability to bind Chang C cells was shown to depend on a single lysine 
residue (Lys240) in the apex of the fiber knob, but distant from the 
sialic acid–binding pocket, creating a more acidic apical region in 
the lysine’s absence (48). HAdV-D26K also lacks a lysine in this po-
sition and has the most acidic electrostatic profile observed in this 
study (Fig. 1).
HAdV-D37K and the identical HAdV-D64K have been shown 
to preferentially interact with the sialic acid–bearing GD1a glycan 
on the corneal cell surface, causing EKC (41). However, it seems 
unlikely that a protein capable of trivalent sialic acid binding is 
completely specific for GD1a, a disialylated glycan, given the wide 
range of available glycan motifs that are di- and trisialylated. The 
GD1a preference may be diminished in HAdV-D19p by the acidic 
surface caused by the two amino acid substitutions, creating a glycan 
preference for tissues outside of the eye. Similarly, HAdV-D26K 
may have a unique glycan preference, driving its tissue tropism toward 
cells with different glycosylation patterns.
The infectivity assays demonstrate sialic acid utilization by 
HAdV-C5/D26K in multiple cell types (Fig. 2D), suggesting either 
that HAdV-D26K binds to a glycosylation pattern conserved in 
all three cell lines or that HAdV-D26K can bind to variable glyco-
sylation motifs. In this assay, a non–sialic acid–using HAdV-C5 
virus (Fig. 2C) pseudotyped with the fiber knob domain of HAdV-D26 
was used. This pseudotype (and HAdV-C5/B35K) retains the fiber 
shaft domain of HAdV-C5, which is 212 amino acids longer than 
the native HAdV-D26 fiber shaft. This could potentially increase 
the avidity of the virus for its receptor, providing greater range 
and flexibility than the equivalent short species D fiber shaft. 
However, it is unlikely to affect the receptor binding that is largely 
governed by the interaction with the knob portion of the fiber protein.
Previous work by Nestić et al. (49) suggested that 3 integrin 
is used by HAdV-D26 during infection and provided evidence for a 
role for CAR as a low-affinity receptor for HAdV-D26, supporting 
our previous structural and biological observations (36). Enhanced 
v3-dependent infection by HAdV-D26 is likely explained by 
secondary interactions with the penton base, which has a shorter 
Arginine, Glycine, Aspartic Acid (RGD)–containing loop than HAdV-C5, 
demonstrated previously using cryo–electron microscopy (50). The 
infectivity of the pseudotyped HAdV-C5/D26K vector described here 
is not limited by this reduced integrin affinity due to the retention of 
the HAdV-C5 penton base protein; thus, conclusions cannot be 
drawn from the present study regarding secondary interactions that 
govern internalization of HAdV-D26.
Our findings clarify the receptor tropism of HAdV-D26 and build 
upon the increasingly complex body of knowledge describing species 
D adenoviruses. The comparison of different sialic acid–binding 
residues suggests greater plasticity regarding the specific residues 
needed for sialic acid binding than previously thought (fig. S4). It 
seems highly likely that many adenoviruses in species D and per-
haps other species may interact with sialic acid in this manner. This 
suggests potential causes of off-target infection by species D–derived 
viral vectors. Conversely, investigation of their specific glycan pref-
erences may enable more tissue-specific targeting. Knowledge of the 
sialic acid–binding mechanism suggests mutations, which may ab-
late sialic acid interaction, enabling engineering of better restricted 
tropisms for future virotherapies. This knowledge regarding HAdV-D26 
receptor can inform clinical practice in the rare cases of acute HAdV-D26 
infection or in the face of adverse reactions to HAdV-D26–based 
vaccines, suggesting that sialic acid–binding inhibitors, such as 
Zanamivir, or trivalent sialic acid derivatives (51) may make effective 
anti–HAdV-D26 therapies.
MATERIALS AND METHODS
Generation of fiber knob pseudotyped HAdV-C5 viral vectors
HAdV-C5 viruses pseudotyped with the HAdV-D26 or HAdV-D35 
fiber knob proteins were generated by the recombineering method, as 
published by Stanton et al. (28). In brief, a marker cassette was gen-
erated using the SacB cassette template (28), with the SacB primer pair 
(table S1) with homology to the HAdV-C5 fiber knob DNA sequence 
before the Threonine, Leucine, Tryptophan (TLW) hinge sequence 
(forward primer) and after the stop codon (reverse primer). This tem-
plate was integrated into a bacterial artificial chromosome (BAC) con-
taining the genome of a GFP-expressing HAdV-C5, which had been 
rendered replication incompetent by deletion of the E1A gene, now con-
taining a marker cassette instead of the HAdV-C5 fiber knob domain.
The DNA sequence of the HAdV-D26K and HAdV-B35K fiber 
knobs was amplified using the 26K and 35K primer pairs, respec-
tively (table S1), containing similar homology to the SacB cassette. 
A second round of recombineering was used to generate the final 
HAdV-C5 pseudotyped genomes by integrating the HAdV-D26K 
and HAdV-B35K polymerase chain reaction (PCR) transcripts. After 
recombineering, the new BACs were sequenced to confirm the correct 
fiber knob DNA sequence.
The BAC DNA for the new vector genomes was transfected into 
293 cell line stably expressing the tetracycline repressor protein (TREx-
293) cells (1.5 × 106), cultured in a T25 cell bind flask (Corning) 
in 5 ml of Dulbecco’s modified Eagle’s medium (DMEM, Gibco) 
supplemented with 10% v/v fetal bovine serum, using the effectene 
system (QIAGEN). Cells were kept in culture until a cytopathic effect 
(CPE) was observed, at which point they were harvested by scraping 
and centrifugation at 1200g for 3 min. Cells were resuspended in 
1 ml of media and frozen at −80°C to create a crude stock of virus. 
TREx-293 cells were cultured at 70% confluency in 5× T150 cell 
bind flasks (Corning) containing 20 ml of complete DMEM and 
then inoculated with 10 l of crude virus stock. Cells were main-
tained in culture until CPE was observed and harvested by scraping 
and centrifugation at 1200g.
Virus was then purified from this cell pellet using the Cesium 
Chloride (CsCl) gradient method (52). Virus titer was determined in 
viral particles per milliliter (VP/ml) using the Pierce BCA Protein Assay 
Kit, assuming 4 × 109 VP/g of protein (52). By using this method, we 
were able to generate HAdV-C5 viruses pseudotyped with the fiber 
knob domains of HAdV-D26 or HAdV-B35. These viruses retained 
the HAdV-C5 fiber shaft domain and were replication incompetent.
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Infectivity assays
Cells were seeded at a density of 30,000 cells per well in a flat-bottomed 
96-well cell culture plate and incubated overnight at 37°C to adhere. 
Cells were washed twice with 200 l of phosphate buffered saline (PBS), 
and 50 l of neuraminidase (Sigma-Aldrich, cat. no. 11080725001) 
was added to the appropriate wells at a concentration of 50 mU/ml, 
diluted in serum-free media, and incubated for 1 hour at 37°C. Cells 
were cooled on ice and washed twice with 200 l of PBS. GFP- 
expressing, replication-incompetent viruses were added to the ap-
propriate wells at a concentration of 2000 or 5000 VP per cell, in 100 l 
of serum-free media, at 4°C, and incubated on ice for 1 hour. Serum- 
free media alone were added to uninfected control wells. Cells were 
washed twice with 200 l of cold PBS, and complete media were 
added (DMEM, 10% fetal calf serum) and incubated for 48 hours at 
37°C. Cells were then trypsinized and transferred to a 96-well V-bottom 
plate, washed twice in 200 l of PBS and fixed in 2% paraformaldehyde 
for 20 min before wash, and resuspended in 200 l of PBS.
Samples were run in triplicate and analyzed by flow cytometry 
on Attune NxT (Thermo Fisher Scientific), analyzed using FlowJo v10 
(FlowJo, LLC), gating sequentially on singlets, cell population, and 
GFP-positive cells. Levels of infection were described in terms of 
total fluorescence, defined as the percentage of GFP-positive cells 
(% + percentage positive) multiplied by the median fluorescence in-
tensity of the GFP-positive population.
Amino acid sequence alignments
Representative whole genomes of HAdV-D64, HAdV-D19p, 
HAdV-D26, and HAdV-D37 were selected from the National Center 
for Biotechnology Information (NCBI), and the fiber knob domain 
amino acid sequences were derived from them, defined as the translated 
nucleotide sequence of the fiber protein (pIV) from the conserved 
TLW hinge motif to the protein C terminus. The fiber knob domains 
were aligned using the European Bioinformatics Institute Clustal 
Omega tool (53).
Generation of recombinant fiber knob protein
SG13009 Escherichia coli harboring pREP-4 plasmid and pQE-30 ex-
pression vector containing the fiber knob DNA sequence were cul-
tured in 20 ml of LB broth with ampicillin (100 g/ml) and kanamycin 
(50 g/ml) overnight from glycerol stocks made in previous studies 
(54). One liter of Terrific Broth (modified, Sigma-Aldrich) containing 
ampicillin (100 g/ml) and kanamycin (50 g/ml) was inoculated with 
the overnight E. coli culture and incubated at 37°C until they reached 
an optical density of 0.6. Isopropyl--d-thiogalactopyranoside was 
then added to a final concentration of 0.5 mM, and the culture was 
incubated at 37°C for 4 hours. Cells were then harvested by centrif-
ugation at 3000g, resuspended in lysis buffer [50 mM tris (pH 8.0), 
300 mM NaCl, 1% (v/v) NP-40, lysozyme (1 mg/ml), and 1 mM 
-mercaptoethanol], and incubated at room temperature for 30 min. 
Lysate was clarified by centrifugation at 30,000g for 30 min and filtered 
through a 0.22-m syringe filter (Millipore, Abingdon, UK). Clarified 
lysate was then loaded onto a 5-ml HisTrap FF nickel affinity chroma-
tography column (GE Healthcare) at 2.0 ml/min and washed with 
5 column volumes into elution buffer A [50 mM tris (pH 8.0), 300 mM 
NaCl, and 1 mM -mercaptoethanol]. Protein was eluted by 30-min 
gradient elution from buffer A to B (buffer A + 400 mM imidazole). 
Fractions were analyzed by reducing SDS–polyacrylamide gel electro-
phoresis (SDS-PAGE), and fiber knob-containing fractions were 
further purified using a Superdex 200 10/300 size exclusion chroma-
tography column (GE) in crystallization buffer [10 mM tris (pH 8.0) 
and 30 mM NaCl]. Fractions were analyzed by SDS-PAGE and pure 
fractions were concentrated by centrifugation in VivaSpin (10,000 
molecular weight cutoff) (Sartorius, Goettingen, Germany) preced-
ing crystallization.
Crystallization and structure determination
Protein samples were purified into crystallization buffer [10 mM 
tris (pH 8.0) and 30 mM NaCl]. The final protein concentration was 
approximately 10 mg/ml. Commercial crystallization screen solu-
tions were dispensed into 96-well plates using an Art-Robbins In-
struments Griffon dispensing robot (Alpha Biotech Ltd.) in sitting 
drop vapor diffusion format. Drops containing 200 nl of screen 
solution and 200 nl of protein solution were equilibrated against a 
reservoir of 60 l of crystallization solution. The plates were sealed 
and incubated at 18°C.
Crystals of HAdV-D26K appeared in PACT Premier conditions 
B01 and B04 [0.1 M MIB (malonic acid, imidazole, and boric acid) 
and 25% w/v polyethylene glycol 1500, pH 4.0 and pH 8.0, respec-
tively], within 1 to 7 days. Crystals were then soaked in reservoir 
solution containing Neu5Ac (Sigma-Aldrich, cat. no. A2388) at a final 
concentration of 10 mM and incubated overnight before harvest. 
Crystals were cryoprotected with reservoir solution to which ethylene 
glycol was added at a final concentration of 25%. Crystals were har-
vested in thin plastic loops and stored in liquid nitrogen for transfer 
to the synchrotron. Data were collected at Diamond Light Source 
beamline I04, running at a wavelength of 0.9795 Å. During data col-
lection, crystals were maintained in a cold air stream at 100°K. Dectris 
PILATUS 6M detectors recorded the diffraction patterns, which 
were analyzed and reduced with XDS (55), Xia2, DIALS (56), and 
autoProc (57). Scaling and merging data were completed with Pointless, 
Aimless and Truncate from the CCP4 package (58). Structures were 
solved with Phaser, COOT was used to correct the sequences and 
adjust the models, and REFMAC5 was used to refine the structures 
and calculate maps. Graphical representations were prepared with 
PyMOL. Reflection data and final models were deposited in the PDB 
database with accession codes 6QU6, 6QU8, and 6FJO. Full crystal-
lographic refinement statistics are given in table S1.
Calculation of electrostatic surface potentials and pIs
HAdV-D37, HAdV-D19p, and HAdV-D26 used PDB IUXA (37), 
PDB 1UXB (37), and PDB 6QU8, respectively, as the input. HAdV-D8 
was calculated using a homology model, generated as described below, 
for input.
The PDB2PQR server (V 2.1.1) (http://nbcr-222.ucsd.edu/
pdb2pqr_2.1.1/) was used to assign charge and radius parameters 
using the PARSE force field and assign protonation states using 
Propka, at pH 7.35. APBS was used to calculate electrostatic surface 
potentials, and the map output was visualized in PyMOL (59).
Homology modeling of adenovirus type 8
The I-TASSER protein structure and function prediction server 
(https://zhanglab.ccmb.med.umich.edu/I-TASSER/) (60) was 
used to generate a homology model of HAdV-D8 based on the 
published sequence of HAdV-D8 (22), using the published struc-
ture of its closest relative (by sequence identity), HAdV-D19p 
(37). The resultant monomer was then copied three times, using 
the HAdV-19p trimer as a template and the monomers aligned 
in PyMOL to generate a model of the complete HAdV-D8K trimer.
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SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/5/9/eaax3567/DC1
Fig. S1. Sialic acid forms a stable interaction with HAdV-D26K 654 at both pH 4.0 (PDB 6QU6) 
and pH 8.0 (PDB 6QU8).
Fig. S2. Structure of sialic acid (Neu5Ac) in a biologically relevant conformation.
Fig. S3. HAdV-D26K forms a similar interaction with sialic acid at both pH 4.0 (PDB 6QU6) and 
pH 8.0 (PDB 6QU8) through a combination of polar, water bridge, and hydrophobic 
interactions.
Fig. S4. Species D adenoviruses conserve known sialic acid–binding residues.
Table S1. Data collection and refinement statistics for structures generated in this study.
Table S2. Primers used to generate recombineering PCR products in this study.
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